Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal study.

[1]  Zhenzhen Liang,et al.  Radiotherapy and Cytokine Storm: Risk and Mechanism , 2021, Frontiers in Oncology.

[2]  G. Bonanno,et al.  Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores. , 2021, JAMA psychiatry.

[3]  R. McIntyre,et al.  Stress, epigenetics and depression: A systematic review , 2019, Neuroscience & Biobehavioral Reviews.

[4]  Stephen R. Williams,et al.  Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. , 2018, American journal of human genetics.

[5]  M. Henry,et al.  Psychosocial Effects of Head and Neck Cancer. , 2018, Oral and maxillofacial surgery clinics of North America.

[6]  R. Marioni,et al.  Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions , 2018, Nature Neuroscience.

[7]  Z. Rosberger,et al.  Prevalence and Risk Factors of Suicidal Ideation among Patients with Head and Neck Cancer: Longitudinal Study , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  Z. Rosberger,et al.  A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post‐treatment: Longitudinal study , 2018, Psycho-oncology.

[9]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[10]  C. Jiang,et al.  Inflammation: The Common Pathway of Stress-Related Diseases , 2017, Front. Hum. Neurosci..

[11]  K. Schmid,et al.  Depression and survival in head and neck cancer patients. , 2017, Oral oncology.

[12]  Markus Perola,et al.  Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors. , 2017, American journal of human genetics.

[13]  T. Padhya,et al.  Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients , 2016, Head & neck.

[14]  S. J. LaMonte,et al.  American Cancer Society Head and Neck Cancer Survivorship Care Guideline , 2016, CA: a cancer journal for clinicians.

[15]  A. Fiocco,et al.  Can anxiety damage the brain? , 2016, Current opinion in psychiatry.

[16]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[17]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[18]  F. Tarazi,et al.  Gene–Environment Interaction in Major Depression: Focus on Experience-Dependent Biological Systems , 2015, Front. Psychiatry.

[19]  S. Clarke,et al.  Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.

[20]  N. Wray,et al.  Research review: Polygenic methods and their application to psychiatric traits. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[21]  Dinesh Vyas,et al.  Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis , 2014, OncoTargets and therapy.

[22]  M. Irwin,et al.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. , 2014, Psychological bulletin.

[23]  F. Lotrich,et al.  Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications , 2013, Neuroscience.

[24]  H. Sayles,et al.  Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. , 2013, JAMA otolaryngology-- head & neck surgery.

[25]  H. Skinner,et al.  The drug abuse screening test. , 2013, Addictive behaviors.

[26]  E. Sternberg,et al.  Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction , 2012, Annals of the New York Academy of Sciences.

[27]  M. Maes,et al.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways , 2012, BMC Medicine.

[28]  Zhiguang Li,et al.  Paradoxical Roles of IL-4 in Tumor Immunity , 2009, Cellular and Molecular Immunology.

[29]  R. Dantzer.  Cytokine, sickness behavior, and depression. , 2009, Immunology and allergy clinics of North America.

[30]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[31]  E. Vokes,et al.  The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.

[32]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Irwin G. Sarason,et al.  A Brief Measure of Social Support: Practical and Theoretical Implications , 1987 .

[34]  P. Ganz,et al.  Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[36]  T. H. Holmes,et al.  The Social Readjustment Rating Scale. , 1967, Journal of psychosomatic research.

[37]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.